Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunization To Prevent Acute COPD Exacerbations (IMPACE Study)

Trial Profile

Immunization To Prevent Acute COPD Exacerbations (IMPACE Study)

Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2018

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Therapeutic Use
  • Acronyms IMPACE Study
  • Sponsors Pfizer
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 14 Dec 2017 Status changed from not yet recruiting to recruiting.
    • 11 Oct 2017 Planned initiation date changed from 29 Sep 2017 to 27 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top